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Silver nanoparticles (AgNPs) are prominent group of nanomaterials and are recognized for their diverse applications
in various health sectors. This study aimed to synthesize the AgNPs using the leaf extract of Artemisia princeps as a
bio-reductant. Furthermore, we evaluated the multidimensional effect of the biologically synthesized AgNPs in
Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma (A549) cells. UV-visible (UV–vis)
spectroscopy confirmed the synthesis of AgNPs. X-ray diffraction (XRD) indicated that the AgNPs are specifically
indexed to a crystal structure. The results from Fourier transform infrared spectroscopy (FTIR) indicate that biomolecules
are involved in the synthesis and stabilization of AgNPs. Dynamic light scattering (DLS) studies showed the average size
distribution of the particle between 10 and 40 nm, and transmission electron microscopy (TEM) confirmed that the
AgNPs were significantly well separated and spherical with an average size of 20 nm. AgNPs caused dose-dependent
decrease in cell viability and biofilm formation and increase in reactive oxygen species (ROS) generation and
DNA fragmentation in H. pylori and H. felis. Furthermore, AgNPs induced mitochondrial-mediated apoptosis in
A549 cells; conversely, AgNPs had no significant effects on L132 cells. The results from this study suggest that
AgNPs could cause cell-specific apoptosis in mammalian cells. Our findings demonstrate that this environmentally
friendly method for the synthesis of AgNPs and that the prepared AgNPs have multidimensional effects such as
anti-bacterial and anti-biofilm activity against H. pylori and H. felis and also cytotoxic effects against human cancer
cells. This report describes comprehensively the effects of AgNPs on bacteria and mammalian cells. We believe
that biologically synthesized AgNPs will open a new avenue towards various biotechnological and biomedical applications
in the near future.
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Nanomaterials often have novel and size-related physico-
chemical properties that differ significantly from their lar-
ger counterparts. Therefore, the growing interest in the
field has driven the production of numerous nanomater-
ials with outstanding optical, magnetic, catalytic, and elec-
trical properties [1,2]. Silver nanoparticles (AgNPs) have
become increasingly popular and have been used in* Correspondence: gsangiliyandi@yahoo.com; jhkim541@konkuk.ac.kr
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reproduction in any medium, provided the origvarious applications such as antibiotic agents in textiles
and wound dressings and in biomedical devices; further-
more, they are one of the most commonly used engi-
neered nanoparticles in commercialized products [3,4].
Since AgNPs have widespread applications, academia and
industry have paid more attention to the production of
AgNPs than to their uses [5].
Among several methods, chemical methods provide an
easy way to synthesize AgNPs in solution, and they are a
commonly used method for the production of AgNPs
[5]. In contrast, physical methods appear to produce a
low yield. Chemical methods, on the other hand, areis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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nents, including metal precursors, reducing agents, and
stabilizing/capping agents. Furthermore, chemical methods
use various toxic materials including hydrazine, citrate, bo-
rohydride, or other organic compounds (e.g., reducing
agents); all these agents can be toxic to living organisms in-
cluding humans. Capping agents are playing an important
role for the stabilization of nanoparticles, for example,
capped AgNPs exhibit better antibacterial activity than un-
capped AgNPs do [6,7]. Biological methods seem to be
valuable for the preparation of AgNPs with controlled size
and shape of the nanoparticles [8-13]. Given that conven-
tional physical methods have low yields and chemical
methods are toxic and consume a lot of energy, the devel-
opment of environmentally friendly approaches has become
the more preferred trend for the field of nanobiotechnology.
Biologically prepared nanomaterials are extremely valuable
because nanoparticles are easily soluble and stable [14]. In
addition, during the biological synthesis of AgNPs, the re-
ducing agent and stabilizer are replaced by molecules pro-
duced by living organisms. These molecular compounds
can be sourced from various living organisms such as bac-
teria, fungi, yeasts, algae, or plants [15]. Biomolecules can
be attached to various types of surfaces via diffusion, ad-
sorption/absorption, covalent cross-linking, and affinity
interaction [16].
Recently, numerous microorganisms have been re-
ported to synthesize AgNPs, including bacteria like
Pseudomonas stutzeri AG259 [17], Bacillus licheniformis
[10], Brevibacterium casei [18], Escherichia coli [9], and
Shewanella oneidensis [19] and fungi like Fusarium oxy-
sporum [20], Trichoderma viride [21], and Ganoderma
neo-japonicum [21]. Extracellular synthesis of various
types of nanoparticles was performed using plants, in-
cluding geranium leaves [22] and lemongrass [23], via
the reduction of aqueous AgNO3 and AuCl4, respect-
ively. Previous studies suggest that leaf and other parts
of plant extracts from various plants, such as Azadirachta
indica [24], Aloe vera [25], Bryophyllum sp. [26], Gliricidia
sepium, Alfalfa sprouts [27,28], aqueous stem extract of ba-
nana [29], and Allophylus cobbe [8], have also been explored
for the synthesis of AgNPs. Compared to other reducing
agents derived from microorganisms, the reduction of the
Ag+ ions with the extracts of plants occurs quickly [22].
Furthermore, biological methods seem to have less time re-
quired for complete reduction and be stable and readily
available in solution at high densities [13]. Similarly, shape
and size, the rate of reduction of metal ions is faster, and
more stable metal nanoparticles are formed using leaf ex-
tracts compared to using microorganisms [28,30].
The green juice of Artemisia princeps used to treat
skin injuries and gastrointestinal disorders [31,32]. Yun
et al. [33] have identified 16 water-soluble phenolic com-
pounds in the leaf water extract of A. princeps, and itsextract contains 192 volatile chemicals [31]. Therefore,
this plant extract can be used as a reducing and stabiliz-
ing agent for the synthesis of AgNPs.
Infections caused by multidrug-resistant bacteria lead
to major public health issues, such as morbidity, mortal-
ity, cost of health care, and the need for implementation
of infection control measures [34]. Parsonnet et al. [35]
reported that bacteria have been linked to cancer by the
induction of chronic inflammation and the production
of carcinogenic bacterial metabolites. A pertinent ex-
ample of the inflammatory mechanism of carcinogenesis
is the Helicobacter pylori infection. H. pylori are known
to cause infection in the stomach and are found in about
two thirds of the world’s population. H. pylori exist and
are adherent to the epithelium of stomach. Non-pylori
gastric Helicobacter organisms cause chronic gastritis
and inflammation in humans [36]. On the other hand,
Fusobacterium nucleatum promotes colorectal carcino-
genesis and intestinal tumorigenesis and modulates the
tumor-immune microenvironment [37,38].
Recent surveys suggest that lung cancer accounts for
23% of all cancer-related mortality, outnumbering the
total mortality of breast, colon, and prostate cancers
combined [39,40]. To address the effect of AgNPs, sev-
eral studies have reported the impact of AgNPs in vari-
ous cell lines, such as BRL4A rat liver cells [41], PC-12
neuroendocrine cells [42], germ line stem cells [43], rat
alveolar macrophages [44], and a human lung carcinoma
cell line, A549 [45]. Recent studies reported that bio-
logically prepared AgNPs have been used for antibacter-
ial and antifungal [46-48]. The results from previous
studies suggest that the generation of reactive oxygen
species (ROS) is an important and general mechanism of
nanoparticle-mediated cytotoxicity through DNA dam-
age, apoptosis, and necrosis [44,49-53]. Although various
studies have addressed the effect of AgNPs in various
cell lines, there has been no study on the multiple func-
tions of biologically prepared AgNPs using A. princeps
on bacteria causing carcinogenesis and human cancer
cells. Therefore, this study was aimed to investigate the
following objectives. Firstly, we aimed to develop an
easy, consistent, cost-effective, and green approach to
the synthesis of colloidal AgNPs using leaf extract of A.
princeps. Secondly, we evaluated the antibacterial and
anti-biofilm activity of AgNPs against H. pylori and non-
pylori Helicobacter felis. Finally, we assessed the cell-
specific cytotoxic effects of AgNPs in normal lung and
lung cancer cells.
Methods
Bacterial strains and reagents
All culture media and chemicals were purchased from
Sigma-Aldrich (St. Louis, MO, USA) unless otherwise
stated. The strains of H. pylori GS-13 and H. felis GS-14
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ture collection. All strains were maintained at −80°C in
Brucella agar (BA) (Sigma, Cream Ridge, NJ, USA) sup-
plemented with 2% fetal calf serum (FCS). Penicillin-
streptomycin solution, trypsin-EDTA solution, RPMI
1640 medium, and 1% antibiotic-antimycotic solution
were obtained from Life Technologies/Gibco (Grand
Island, NY, USA). Silver nitrate, fetal bovine serum (FBS),
and the in vitro toxicology assay kit were purchased from
Sigma-Aldrich (St. Louis, MO, USA).Synthesis and characterization of AgNPs
A. princeps leaves were collected from plants growing in
the Jeju Island, South Korea, and stored at 4°C until
needed. The leaf extract was prepared according to
method described earlier [54]. Briefly, the filtered extract
was used for the synthesis of AgNPs by adding 10 mL
(1 mg/mL) to 100 mL of 1 mM AgNO3 in an aqueous
solution at room temperature. The bio-reduction of the
AgNO3 was monitored spectrophotometrically between
300 and 600 nm. The synthesized particles were charac-
terized according to methods described previously [9].
The size distribution of the dispersed particles was mea-
sured using a Zetasizer Nano ZS90 (Malvern Instruments
Ltd., Malvern, UK). X-ray diffraction (XRD) analyses
were carried out on an X-ray diffractometer (Bruker D8
DISCOVER; Bruker AXS GmBH, Karlsruhe, Germany).
The high-resolution XRD patterns were measured at
3 Kw with a Cu target using a scintillation counter
(λ = 1.5406 °A) at 40 kV and 40 mA and were recorded
in the range of 2θ = 5°–80°. Further characterization of
changes in the surface and surface composition was
performed by Fourier transform infrared spectroscopy
(PerkinElmer Spectroscopy GX, PerkinElmer, Waltham,
MA, USA). Transmission electron microscopy (TEM),
using a JEM-1200EX microscope, was performed to de-
termine the size and morphology of AgNPs. TEM im-
ages of AgNPs were obtained at an accelerating voltage
of 300 kV.Determination of minimum inhibitory concentrations of
AgNPs and in vitro killing assay
Minimal inhibitory concentration (MIC) of H. pylori and
H. felis was determined as described previously [8]. To
determine the MICs of AgNPs, H. pylori and H. felis
were then exposed to different concentrations of AgNPs.
Growth was monitored using a microtiter ELISA reader
(EMax, Molecular Devices, Sunnyvale, CA, USA) by
monitoring the absorbance at 600 nm. The MIC of
AgNPs was defined as the lowest concentration that
inhibited the visible growth of bacteria. The in vitro kill-
ing assay was performed as described previously [8].Determination of biofilm activity using the tissue culture
plate method
Inhibition of biofilm was determined as described earlier
with suitable modifications [8,55]. Briefly, the cells were
grown in Brucella broth supplemented with 2% FCS and
individual wells of sterile, 96-well flat-bottom polystyr-
ene tissue culture plates (TCPs) were filled with 180 μL
of a single bacterial species (1 × 106/mL). The cell cul-
ture plates were then incubated with AgNPs for 24 h at
37°C. After incubation, the media were removed, and
the wells were washed three times with 200 μL sterile
distilled water to remove non-adherent bacteria. The
crystal violet solutions in water were added for 45 min.
The wells were then washed five times with 300 μL of
sterile distilled water to remove excess stain. The ab-
sorbance of each well was measured at 595 nm using a
microtiter ELISA reader. The percent inhibition of bio-
film activity was calculated as described earlier [8,55].
Measurement of ROS generation in bacteria
ROS was determined according to the manufacturer’s in-
structions and according to previous publications [8,49,56].
All test strains were grown in BB. Cell suspensions were in-
cubated with AgNPs at 37°C on a rotary shaker for 12 h.
Aliquots were then removed and spun in a microfuge, and
the absorption of the supernatant was measured at 450 nm.
Cell culture
Human lung cancer A549 cells and normal human lung
L-132 cells were obtained from the Korean Cell Bank
(Seoul, Korea) and cultured in RPMI 1640 medium sup-
plemented with 10% FBS and 100 U/mL penicillin-
streptomycin at 5% CO2 and 37°C. At 75% confluence,
the cells were harvested using 0.25% trypsin and subcul-
tured in 75-cm2 flasks, 6-well plates, or 96-well plates.
Cells were allowed to attach the surface for 24 h before
treatment. The medium was replaced three times per
week, and the cells were passaged at subconfluency.
Cell viability and cytotoxicity assays
Cell viability was measured using a Cell Counting Kit-8
(CCK-8; Dojindo Laboratories, Kumamoto, Japan).
Briefly, A549 and L132 cells were plated onto 96-well
flat-bottom culture plates with various concentrations of
AgNPs. All cultures were incubated for 24 h at 37°C (5%
CO2 in a humidified incubator). CCK-8 solution (10 μL)
was added to each well, and the plate was incubated for
another 2 h at 37°C. Absorbance was measured at 450
nm with a microplate reader (Multiskan FC; Thermo
Fisher Scientific Inc., Waltham, MA, USA). Cytotoxicity
was assessed using supernatants from the medium in
lactate dehydrogenase (LDH) assays. An LDH Cytotox-
icity Detection kit (Takara Bio Inc., Tokyo, Japan) was
used according to the manufacturer’s protocol, and the
Figure 1 Synthesis and characterization of AgNPs using leaf
extract of A. princeps. The inset shows tubes containing samples of
silver nitrate (AgNO3) after exposure to 60 min (1), leaf extract (2),
and AgNO3 plus leaf extract (3). The color of the solution turned
from pale yellow to brown after 15 min of incubation, indicating the
formation of silver nanoparticles. The absorption spectrum of AgNPs
synthesized by leaf extract exhibited a strong broad peak at 410 nm,
and observation of such a band is assigned to surface plasmon
resonance of the particles.
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ROS (H2-DCFH-DA) assay
Human lung normal L132 cells and A549 human lung
epithelial adenocarcinoma cells were cultured in mini-
mum essential medium (Hyclone Laboratories, Logan,
UT, USA) containing 10 μM H2-DCFDA in a humidified
incubator at 37°C for 30 min. Cells were washed in PBS
(pH 7.4) and lysed in lysis buffer (25 mM HEPES [pH 7.4],
100 mM NaCl, 1 mM EDTA, 5 mM MgCl2, and 0.1 mM
DTT supplemented with a protease inhibitor cocktail).
Cells were cultured on coverslips in a 4-well plate. Cells
were incubated in DMEM containing 10 μM H2-DCFDA
at 37°C for 30 min. Cells were washed in PBS, mounted
with Vectashield fluorescent medium, and viewed with a
fluorescence microscope.
JC-1 assay
The change in mitochondrial transmembrane potential
was evaluated using the cationic fluorescent indicator
JC-1 (Molecular Probes, Eugene, OR, USA). J-aggregates
of intact mitochondria were fluorescent red with an
emission at 583 nm, and J-monomers in the cytoplasm
were fluorescent green with emission at 525 nm and an
excitation wavelength of 488 nm. A549 and L132 cells
were incubated in RPMI containing 10 μM JC-1 at 37°C
for 15 min, washed with PBS, and transferred to a clear
96-well plate. Cells were also cultured on cover slips, in-
cubated in DMEM containing 10 μM JC-1 at 37°C for
15 min, and then washed with PBS. Finally, cells were
mounted using Vectashield fluorescent medium and vi-
sualized with fluorescence microscopy.
Statistical analyses
All assays were carried out in triplicate and the experi-
ments were repeated at least three times. The results are
presented as means ± SD. All experimental data were
compared using Student’s t-test. A p value less than 0.05
was considered statistically significant.
Results and discussion
Synthesis and characterization of AgNPs using leaf
extract
Synthesis of AgNPs using leaf extract was performed ac-
cording to a previously described method [8]. The leaf
extract of A. princeps was used as both a reducing and
stabilizing agent. In a typical reaction procedure, 10 mL
of A. princeps leaf extract was added to 100 mL of 1
mM aqueous AgNO3 solution under magnetic stirring at
room temperature for 60 min. The color change was ob-
served by visual observation in the tube, which contains
AgNO3 solution with leaf extract. The mixture of silver
nitrate and leaf extract changed rapidly from green to abrown suspended mixture after 15 min, whereas silver
nitrate without leaf extract exhibited no color change
(Figure 1 inset). The synthesis of AgNPs using the leaf
extract was confirmed by the color change. To monitor
the synthesis and stability of AgNPs, the absorption
spectra of the AgNPs were observed using UV-visible
spectroscopy. The color of the solutions changed from
pale yellow to yellowish brown to deep brown depending
on the extract concentration; this indicates that AgNP
formation occurs due to the excitation of surface plas-
mon vibration (SPR) of the particles. The typical SPR of
AgNPs was observed between 410 and 420 nm (Figure 1).
XRD analysis of AgNPs
The crystalline nature of the AgNPs was confirmed
using XRD, and the XRD pattern revealed Bragg’s reflec-
tions that represent the face-centered cubic structure of
silver. Figure 2 shows the XRD patterns of dried AgNPs
synthesized with A. princeps leaf extract. The XRD pat-
terns indicated that the structure of AgNPs is face-
centered cubic (fcc) [8,57]. The sharp XRD peaks at 2θ
of 31.9 and 45.3 are attributed to the (111) and (200)
crystallographic planes. The two diffraction peaks could
be indexed as (111), (200), (220), (311), and (222) planes
of fcc silver (JCPDS, fileno.04-0783) [24]. A comparison
made between our XRD spectrum and the standard con-
firmed that our silver particles exhibited Bragg’s reflec-
tions of silver. Hence, the XRD results clearly show that
the AgNPs are crystalline. Interestingly, the XRD pattern
shows no impurities as reported earlier [58]. From the
Figure 2 XRD pattern of AgNPs. A representative X-ray diffraction (XRD) pattern of silver nanoparticles formed after reaction of leaf extract with
1 mM of silver nitrate (AgNO3) for 60 min at 60°C. The XRD pattern shows two intense peaks in the whole spectrum of 2θ values ranging from 20
to 70. The intense peaks were observed at 2θ values of 31.9 and 45.31 corresponding to (111) and (200) planes for silver, respectively.
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the average particle size was 20 ± 3.5 nm. Remarkably,
the absence of peaks from other phases suggests that
nanoparticles with single-phase Ag with cubic structure
were synthesized. Awwad et al. [58] reported that using
carob leaf extract as a reducing and stabilizing agent
produced 5- to 50-nm sizes of AgNPs. Recently, Mukherjee
et al. [59] reported that the AgNPs synthesized with leaf ex-
tract from Olax scandens were mostly monodispersed and
spherical (20 to 60 nm) along with very few larger particles
(approximately 90 nm). Our studies suggest that A. princeps
shows a significantly uniform distribution of particles with
an average size of 20 nm.
FTIR spectra of AgNPs
To identify the possible biomolecules involved in the re-
duction of the Ag+ by the extract of leaf broth, we used
Fourier transform infrared spectroscopy (FTIR) mea-
surements [22]. The silver nitrate solution after complet-
ing the reduction of Ag+ ions and the formation of
AgNPs was centrifuged at 10,000 rpm for 15 min to iso-
late the AgNPs from free proteins [22]. The FTIR
spectrum of AgNPs exhibits peaks at 1,727 and 1,638
cm−1 that are attributed to ester CdO groups of chloro-
phyll [22,60]. It is well known that water-soluble frac-
tions of A. princeps leaves contain large amounts of
secondary metabolites; these secondary metabolites may
favor the synthesis of nanoparticles as reducing agents
[31]. Terpenoids possibly contribute to the reduction of
the silver ions that, in the process, are oxidized to car-
bonyl groups, resulting in a band at 1,727 cm−1. During
the formation of AgNPs, the peak corresponding to the
amide I band at 1,638 cm−1 broadened, which indicates
capping of the AgNPs by protein (Figure 3). The absorptionpeak at 1,638 cm−1 may be ascribed to the carbonyl stretch
in proteins, while the peaks at 3,398 cm−1 represent the
OH stretching in alcohols and phenolic compounds
[61-63]. The strong intense peaks at 1,387 and 1,638 cm−1
correspond to C-N stretch vibrations, as well as to the
amide I bands of proteins in the leaf extract. The absorption
peak at 1,638 cm−1 is close to that reported for native pro-
teins [64]. This suggests that proteins are interacting with
biosynthesized nanoparticles, and their secondary structure
were not affected during the reaction with Ag+ ions. Pro-
teins are able to bind with silver or gold nanoparticles either
through free amine groups or cysteine residues in the pro-
teins [65]. A similar mechanism may be involved when the
leaf extract from A. princeps caps the AgNPs, thereby sta-
bilizing the particles. Similarly, several other researchers
found a similar FTIR pattern of AgNPs using geranium leaf
extract [22], Ocimum sanctum leaf extract [66,67], and
Camellia sinensis [62]. The results obtained from FTIR
spectroscopy suggest that the leaf extracts have the ability
to reduce and stabilize the AgNPs. The present results
agree with those reported previously for Rhinacanthus
nasutus [68], Thevetia peruviana [69], latex of Jatropha-
curcas [67], O. sanctum leaf extract [63,66], and C.
sinensis [62].
Dynamic light scattering analysis of AgNPs
Dynamic light scattering (DLS) measurement was used
to determine the size of synthesized AgNPs in aqueous
solution. Powers et al. [70] proposed DLS to be one of
the most valuable and useful technique to evaluate par-
ticle size and size distribution of any nanomaterial in so-
lution [71]. Specifically, particle size, size distribution,
particle morphology, particle composition, surface area,
surface chemistry, and particle reactivity in solution are
Figure 3 FT-IR spectrum of silver nanoparticles synthesized by treating AgNO3 with leaf extract.
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DLS characterizes the size of colloidal dispersions using
the illumination of a particle or molecule suspension
undergoing Brownian motion by a laser beam [72]. The
present study used DLS, in conjunction with TEM, to
evaluate the size distribution. The DLS pattern revealed
that the synthesized AgNPs showed an average size of
40 ± 15 nm (Figure 4). From the figure, the particles ob-
tained were monodisperse in the range 10 to 100 nm
and had an average size of 40 nm. This size is larger
than the TEM data, which is due to the hydrodynamic
size of nanomaterials. Singhal et al. [63] reported thatFigure 4 Size distribution analysis by dynamic light scattering (DLS).
particles were mixed thoroughly via sonication and vortexing, and samplesthe AgNPs synthesized using O. sanctum leaf extract
showed an average diameter of 22.38 nm. Umoren et al.
[72] reported that the average size of the synthesized
AgNPs using red apple fruit extract is around 150 nm.
The sizes and shapes of metal nanoparticles are influ-
enced by a number of factors, including pH, precursor
concentration, reductant concentration, time of incuba-
tion, temperature, and the method of preparation [9].
Size and surface analysis of AgNPs by TEM
TEM is widely used to directly and accurately analyze
the structural and size information of nanoparticles.Silver nanoparticles were dispersed in deionized water and the
were measured at 25 μg/mL.
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morphologies [71]. Next, we examined the size and sur-
face morphologies of synthesized AgNPs. TEM micro-
graphs of AgNPs show distinct, uniform, and spherical
nanoparticles that were widely separated. The average
particle size was estimated from more than 300 particles
and determined to be between 5 and 30 nm with an
average size of 20 nm (Figure 5A). It was observed that
AgNPs were evenly distributed in the analyzed sample
(Figure 5B). Shankar et al. [22] reported that the size of
the nanoparticles produced by geranium leaf extract
from 16 to 40 nm. Mukherjee et al. [59] reported that
synthesized AgNPs using O. scandens leaf extract shows
almost monodispersed spherical nanoparticles (20 to 60
nm) along with very few bigger particles (approximately
90 nm). Interestingly, our data suggest that using A.
princeps could produce smaller AgNPs, which are better
for antimicrobial activity and anticancer activity. The
image obtained from TEM study shows that the morph-
ology of AgNPs is spherical, which is in agreement with
the shape of the SPR band in the UV-visible (UV–vis)
spectrum. The particle size could be controlled by vary-
ing the parameters such as temperature, pH, and con-
centration of AgNO3 [9].
Determination of MIC of AgNPs against H. pylori and H.
felis
In response to the overwhelming evidence linking H.
pylori infection to human cancer, the International
Agency for Research on Cancer listed H. pylori as a
definite human oncogenic agent in 1994 [36,73-75].
Therefore, we were interested in finding out the MIC of
AgNPs against both pylori and non-pylori strains, such
as H. pylori and H. felis, respectively. The MIC of
AgNPs was defined as the lowest concentration that
completely inhibited visible growth of bacteria afterA
Figure 5 Size and surface morphology of AgNPs analysis by TEM. (A)
diameter of silver nanoparticles (AgNPs) using TEM. The average range of o
transmission electron microscopy images.incubation at 37°C for 24 h. In these studies, H. pylori
and H. felis were used as a model bacteria for Gram
negative to evaluate antibacterial activities of AgNPs.
Both strains were incubated with the different concen-
tration of AgNPs for 24 h in Brucella broth. The media
without AgNPs were used as a control. The H. pylori
and H. felis bacterial counts were significantly reduced
by the treatment with AgNPs than control. The level of
MIC of AgNPs was found to be 5.0 and 5.5 μg/mL to H.
pylori and H. felis, respectively. The toxic effects of
AgNPs depend on size, surface area, and surface func-
tionalization which are major factors that influence bio-
kinetics and toxicity in bacteria [76,77].
Dose-dependent antibacterial effects of AgNPs
The antimicrobial effect of Ag+ ions has been well docu-
mented and it has been applied [78,79]. We are inter-
ested to investigate the potential of antibacterial activity
of biologically synthesized AgNPs against H. pylori and
H. felis. The dose-dependent antibacterial activity of
AgNPs was determined using representative Gram-
negative bacterial strains, H. pylori, and H. felis. Figure 6
shows the toxicity of biologically synthesized AgNPs
(20 nm) at concentrations of 0.01 to 5 μg/mL to H.
pylori and H. felis. Cell viability was reduced as the
concentrations of the AgNPs increased [8]. For each
bacterial strain, no growth was observed at their re-
spective MIC values. Thus, these represent bacteri-
cidal concentrations for each specific bacterial strain.
The plant extract-mediated AgNPs exhibited signifi-
cant antimicrobial activity. For example, Li et al. [80]
reported that 10 μg/mL (AgNPs) could completely in-
hibit the growth of 107 CFUs/mL of E. coli in liquid
MHB. Anthony et al. [81] reported that 10 μg/mL
treatments of AgNPs with an average size of 40 nm


















Several fields were photographed and used to determine the
bserved diameter was 20 nm. (B) Histogram of Particle size from
Figure 6 Effect of AgNPs on cell survival of H. pylori and H. felis. Dose-dependent effects of AgNPs on bacterial survival. All test strains were
incubated in the presence of different concentrations of AgNPs. Bacterial survival was determined at 4 h by a CFU assay.
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bial activity of Ag nanoparticles against bacteria and
yeast, and they found that E. coli shows more sensitiv-
ity at low concentration of Ag nanoparticles, whereas
the effects of AgNPs on Staphylococcus aureus were
mild. Our studies show that a promising inhibitory ef-
fect of AgNPs against tested strains was observed with
concentration of 5 μg/mL. Previous studies showed that
AgNPs are effective antimicrobial agents and mecha-
nisms of toxicity attached with cell membrane and
disturb their functions such as permeability and respir-
ation [77,82-84]. Our results suggest that AgNPs syn-
thesized using plant extract of A. princeps seem to be
smaller in size, which may provide more bactericidal ef-
fects than larger particles.Figure 7 Time-dependent effect of AgNPs on H. pylori and H. felis. Tim
were incubated in the presence of different concentrations of AgNPs. BacteTime-dependent antibacterial activity of AgNPs
The time-dependent antibacterial efficiency of AgNPs
was determined in H. pylori and H. felis. The loss of
viability of H. pylori and H. felis was counted at dif-
ferent time points such as 1, 2, 3, and 4 h (Figure 7).
The loss of H. pylori viability increased after 1-h in-
cubation with AgNPs from 1.2 to 1.0 optical density,
whereas H. felis shows a weak difference between
treated and untreated; however, both strains showed
a sharp decrease of growth from 1.0 to 0.6. By in-
creasing the time of incubation, the loss of viability
increased after 3 to 4 h of incubation. The division
of cell death occurred in all 4 h of incubation; how-
ever, a large fraction of cell death occurred in the
earlier hour of incubation. The treated groups showe-dependent effects of AgNPs on bacterial survival. All test strains
rial survival was determined at 4 h by a CFU assay.
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control strains show health and no significant growth
impairment.
Anti-biofilm activity of AgNPs against H. pylori
Biofilms are surface-bound communities of microbial
cells found in oligotrophic environments and are strongly
implicated in bacterial virulence [55,85]. Yonezawa et al.
[55] reported the biofilm activity of H. pylori. However, the
anti-biofilm activity of AgNPs against H. pylori is recog-
nized that it is still in its infancy. The purpose of the experi-
ment was to design to investigate the inhibitory effects of
AgNPs on biofilm formation by H. pylori. In this experi-
ment, tissue culture plate was to assess the effect of AgNPs
on inhibition of biofilm formation by H. pylori. Previously,
we reported the antibacterial and anti-biofilm effects of
AgNPs in P. aeruginosa [86]; therefore, this study was
aimed to investigate the dose-dependent ability of AgNPs
to inhibit the activity of biofilms by the human pathogen H.
pylori, which is an unexplored microorganism. All test
strains were grown for 24 h in microtiter plate wells and
then treated with concentrations of AgNPs of 0.01 to 5 μg/
mL (Figure 8). Treatment of H. pylori and H. felis for 24 h
with 5 μg/mL of AgNPs shows decreased biofilm activity by
more than 90 to 95%. Kalishwaralal et al. [86] reported that
AgNPs inhibit biofilm formation against P. aeruginosa and
Staphylococcus epidermidis using 100 nM of AgNPs which
resulted in a 95 to 98% reduction in biofilm formation.
Ansari et al. [87] demonstrated that AgNPs are able to in-
hibit production of exopolysaccharides, which are essential
for biofilm formation. AgNPs also enhanced quorum
quenching activity against S. aureus biofilm and prevention
of biofilm formation [88]. Martinez-Gutierrez et al. [89]
demonstrated that AgNPs could effectively prevent theFigure 8 Anti-biofilm activity of AgNPs. The anti-biofilm activity of AgNP
of AgNPs for 24 h in a 96-well plate. The results are expressed as the mean ± SD
Treated groups showed statistically significant differences from the control grouformation of biofilms and kill bacteria in established bio-
films. Taken together, our studies suggest that leaf extract
A. princeps-mediated synthesis of AgNPs could be a viable
anti-biofilm agent.
Effect of AgNPs on ROS production
To investigate the effect of AgNPs on ROS produc-
tion, which is one of the key factors for bacterial cell
death, H. pylori and H. felis were selected as a model
bacterium to study the effect of ROS released from
the surface of AgNPs on cell death. The bacterial cells
were incubated with AgNPs for 12 h and then we
measured the ROS production. The levels of ROS in
AgNP- or H2O2-treated cells were higher, compared
to the level of ROS in control cells [56]. H2O2 led to
slightly higher ROS levels compared to the level of
ROS in the AgNP-treated cells. Further, we tested if
pre-incubation of cells with GSH or NAC could pre-
vent ROS generation by AgNPs and found that these
intracellular antioxidants protected H. pylori and H.
felis from AgNPs and H2O2 (Figure 9). The data ob-
tained from this study suggest that cell death is medi-
ated by ROS production, which might alter the
cellular redox status [56].
ROS is a natural by-product of the metabolism of re-
spiring organisms [76]. Induction of ROS synthesis leads
to the formation of highly reactive radicals that destroy
the cells. The possible mechanisms of H. pylori and H.
felis cell death are due to membrane damage by AgNPs
which relates to metal depletion, that is, the formation
of pits in the outer membrane and change in membrane
permeability by the progressive release of lipopolysac-
charide (LPS) molecules and membrane proteins [90].
Previous studies proposed that the sites of interactions was assessed by incubating all test strains with different concentrations
of three separate experiments each of which contained three replicates.
p by Student’s t-test (p < 0.05).
Figure 9 Effect of AgNPs on the generation of ROS. All test strains were treated with 1 μg/mL AgNPs for 12 h. ROS generation was measured
by the XTT assay. The results are expressed as the means ± SD of three separate experiments, each of which contained three replicates. Treated
groups showed statistically significant differences from the control group by Student’s t-test (p < 0.05).
Figure 10 Detection of AgNP-induced apoptosis by DNA
fragmentation. For DNA fragmentation analysis, cells were
treated with 1 μg/mL for 12 h. After incubation, DNA extracted
from cells and resolved on agarose gel electrophoresis. Lane 1, 1
kB ladder; lane 2, control from H. pylori; lane 3, control from H.
felis; lane 4, 1 kB ladder; lane 5, AgNP-treated H. pylori; lane 6,
AgNP-treated H. felix.
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containing proteins present in the bacterial membrane
proteins [91-95]. Previous studies suggest that ROS may
be a common mechanism of cell death induced by bac-
tericidal antibiotics [96-99].
DNA fragmentation
Apoptotic cell death is essential to the development and
long-term viability of multicellular organisms [96,100,101].
Apoptosis can be induced in response to variety of intra
and extracellular stimuli and stresses. A characteristic fea-
ture of apoptosis is the cumulative effects of biochemical
and morphological changes which include cell-cycle arrest,
halt DNA repair and homeostasis, inactivate apoptosis in-
hibitor proteins, and facilitate ultra-structural modifications,
breakdown of cellular contents, and marking for death
[96,102]. Previously, several studies shows that bactericidal
antibiotics induces the generation of ROS, via a common
metabolic mechanism, which contributes to drug-induced
killing [98,103,104], which is due to production of ROS.
Furthermore, Dwyer et al. [96] demonstrated that drug-
induced bacterial cell death is indeed accompanied by DNA
fragmentation, chromosomal condensation, and loss of
structural integrity, all markers of eukaryotic apoptosis. We
are interested to determine whether AgNPs could induce
DNA fragmentation, which are physiological hallmarks of
apoptosis in bacteria. To examine whether ROS generation
by AgNPs leads to DNA damage in H. pylori and H. felis,
DNA was extracted from both AgNP (1 μg/mL) treated
cells with of AgNPs for 12 h and analyzed for the occur-
rence of DNA fragmentation. The results show that both
strains treated with AgNPs for 12 h show laddering of
DNA, specific DNA smearing is a characteristic feature of
cell death [56], whereas untreated groups did not showsignificant fragmentation (Figure 10), which suggests that
AgNPs are able to induce fragmentation of DNA free radi-
cals produced by AgNPs. It is known that intracellular oxi-
dative stress could be accelerated by NPs by disturbing the
equilibrium between the oxidant and antioxidant processes
[77]. ROS typically includes the superoxide radical (O2−),
hydrogen peroxide (H2O2), and hydroxyl radical (OH),
which cause damage to cellular components, including
DNA and proteins [105,106]. ROS induces mitochondrial
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to trigger the apoptotic process [107]. The results drawn
from DNA smearing studies indicate that AgNPs derived
from A. princeps one of the potent inducer of ROS and
eventually this ROS generation induces DNA fragmentation
of cells. Although several studies have reported the antibac-
terial activity of biologically synthesized AgNPs in several
microorganisms, this report describes that the maximum
antibacterial and anti-biofilm effect with the lowest concen-
tration of AgNPs in H. pylori and H. felis.Effect of AgNPs on cell viability of L132 and A549 cells
Although several studies showed the potential toxicity
of AgNPs in cancer cells [51,54], to see the cell-specific
activity of AgNPs, the effects of AgNPs on cell viability
were evaluated using human lung cancer A549 cells
and normal human lung L-132 cells; we selected A549
cancer cells and L-132 normal cells for our study be-
cause entry through the respiratory tract is one of the
most frequent routes by which nanomaterials may
enter the body. It was also to compare the cytotoxicity
of nanoparticles in cancer cells and normal cells.
Therefore, we are interested to investigate whether nor-
mal cells and cancer cells differentially respond to
AgNPs, to examine the effect of both the cells which
were treated with various concentrations of AgNPs and
measured cell viability. After 24 h of treatment with
different AgNP concentrations, the A549-treated cells
showed a dose-dependent decrease in cell viability
compared to that of the control group, whereas there is
no significant difference between AgNP-treated L132
cells and control group (Figure 11). The most apparent
and noticeable effect following exposure of cells to
toxic materials is the alteration in the cell shape orFigure 11 Effect of AgNPs on cell viability of L 132 and A549 cells. Ce
cytotoxicity was determined by the MTT method. The results are expressed
contained three replicates. Treated groups showed statistically significant dmorphology of the monolayer culture [108]. The cell
viability assays shows that A549 cells have significant
inhibitory effect of AgNPs and are more sensitive than
L132 lung normal cells (Figure 11). Our studies are
consistent with previous studies which show that AgNP
exposure could induce the changes of cell shape, re-
duce cell viability, increase LDH release, and finally re-
sult in cell apoptosis and necrosis [48,51,53,109-111].
Effect of AgNPs membrane leakage
To investigate the effect of AgNPs on membrane integ-
rity; L132 and A549 cells were treated with various con-
centrations of AgNPs for 24 h. The results suggest that
cell membrane leakage was dose dependent and signifi-
cantly affected (Figure 12). The results from the LDH
assay were consistent with cell viability; with increasing
concentrations of AgNPs, the cells became gradually
more cytotoxic. The increase of LDH leakage was due to
abrupt cell membrane lysis following cell death, which
suggests that the membrane leakage was a consequence
of the apoptosis [54]. Interestingly, AgNP shows more
toxicity in A549 cells, whereas L132 cells have no signifi-
cant leakage of membrane. The results suggest that
AgNP is targeting on cancer cells rather than normal in
given concentrations. Similarly, Hussain et al. [41] ob-
served that BRL 3A rat liver cells exposed to AgNPs for
24 h resulted in a concentration-dependent increase in
LDH leakage and exhibited significant cytotoxicity at
10–50 μg/mL. Park et al. [112] reported that AgNPs sig-
nificantly affect membrane integrity in L929 fibroblasts.
Song et al. [113] observed dose- and time-dependent re-
duction of cell viability and decreased the activities of
superoxide dismutase and glutathione peroxides. Lee
et al. [114] reported that the level of LDH was increased
to 210% when cells were exposed to 48 h in a culturells were treated with various concentrations of AgNPs for 24 h, and
as the mean ± SD of three separate experiments each of which
ifferences from the control group by Student’s t-test (p < 0.05).
Figure 12 Effect of AgNPs on LDH release from L 132 and A549 cells. Lactate dehydrogenase (LDH) was measured by changes in optical
density due to NAD+ reduction monitored at 490 nm, as described in materials and methods. The results are expressed as the mean ± SD of
three separate experiments each of which contained three replicates. Treated groups showed statistically significant differences from the control
group by Student’s t-test (p < 0.05).
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Choi et al. [115] found that exposure to layered metal
hydroxide (LMH), for 72 h, resulted in a remarkable
concentration-dependent increase in LDH leakage from
A549 and HOS cells, but not from L-132 and HeLa cells,
suggesting that the membrane damage caused by LMH
depends on the cell types. Similarly, we found that mem-
brane damage was observed only A549 cells. We found
that concentration of 30 μg/mL is sufficient to induce
50% cell death, which is found to be IC50. Therefore,
this concentration was used for further analysis of
ROS and apoptosis assay.
AgNPs induce time-dependent ROS generation
Since nanoparticles like carbon nanotubes [116], LMH
[115], AgNPs [49,56], zinc oxide nanoparticles [117],
graphene, and graphene-related nanomaterials [118]
are toxic due to oxidative stress and lead to increased
apoptosis. We examined the ability of AgNPs to in-
duce oxidative stress by measuring ROS with carboxy-
H2DCFDA in L132 and A549 cells. The cells were
treated with 30 μg/mL of AgNPs at various time
points such as 0, 6, 12, and 24 h. The increase in
fluorescence intensity is directly proportional to the
generation of ROS. A549 cells exposed to 30 μg/mL
AgNPs for 24 h showed a dose-dependent increase in
fluorescence intensity, indicating the generation of
ROS and oxidative stress (Figure 13), whereas L-132
cells showed a very weak fluorescence at 24 h indicat-
ing AgNPs could target selective toxicity to cancer
cells. Similarly, Choi et al. [115] found selective ROS
generation by LMH in A549 cells. Akhtar et al. [117]
also found that zinc oxide nanoparticles producesignificant toxicity via ROS generation in all cancer
cells including HepG2, A549, and BEAS-2B except
normal rat cells (astrocytes and hepatocytes). In many
pathological condition, inflammation-induced oxida-
tive stress and ROS also plays an important role in
lipid peroxidation followed by membrane damage
[119].
AgNPs induce mitochondrial-mediated apoptosis
Mitochondrial transmembrane potential (MTP) is an
early event in apoptosis. JC-1 monomer assay was used
to evaluate the effect of AgNPs in mitochondrial mem-
brane permeability. Mitochondria-mediated apoptosis
undergoes two major changes which include changes in
the permeabilization of the outer mitochondrial mem-
brane and the loss of the electro chemical gradient [120].
The permeabilization of the outer membrane is tightly
regulated by a member of the Bcl-2 family. Membrane
depolarization is mediated by the mitochondrial perme-
ability transition pore. Prolonged mitochondrial perme-
ability transition pore opening leads to a compromised
outer mitochondrial membrane [120,121]. As shown in
Figure 14, decreases in mitochondrial energy transduction
were observed following treatment of AgNPs for 12 h,
illustrated by disappearance of red fluorescence and
emergence of green fluorescence in A549 cells, whereas
the green fluorescence was very weak in L132 cells
treated with AgNPs at the same concentration and same
time, indicating that AgNPs could cause MTP collapse
significantly higher in cancer cells than normal cells.
These results suggest that AgNPs could induce apop-
tosis through a mitochondria-mediated apoptosis path-
way. A similar observation was made in RAW264.7 cells
Figure 13 AgNPs induce generation of ROS in AgNP-treated L 132 and A549 cells. Fluorescence images of A549 (A) and L132 (B) cells
without silver nanoparticles (AgNPs) (0) and cells treated with AgNPs 30 μg/mL and incubated at different time points. The image shows
significant formation of hydrogen peroxide inside the A549 cells, whereas weak fluorescence was observed in L132 cells.
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mitochondria-mediated apoptosis through failure of
MTP [122]. Mitochondria play an important role in
apoptosis, via the intrinsic apoptotic program. An in-
trinsic apoptotic pathway is the depolarization of the
mitochondrial (mt) membrane. Depolarized mt is a
result of the formation of mt permeability transition
(PT) pores [123,124]. mt PT has been associated with
various metabolic consequences such as halted func-
tioning of the electron transport chain with associated
elevation in ROS and decreased production of ATP[125]. Govender et al. [123] observed a significant in-
crease in mt depolarization after AgNP treatment, with
an accompanying decrease in ATP concentration. They
concluded that the high levels of bax expression, high
mt depolarization, and decreased ATP suggest that
AgNP induces cellular apoptosis in cancerous lung cells
via the intrinsic apoptotic pathway. Several studies also
suggest that nanoparticles seem to be localized in mito-
chondria and cause oxidative stress as well as potentiate
structural damage and eventually lead to toxicity to the
cells [44,126-128].
Figure 14 AgNPs modulate mitochondrial transmembrane potential. Changes in mitochondrial transmembrane potential (MTP) was
determined using the cationic fluorescent indicator, JC-1. Fluorescence images of control A549 cells and L132 cells (without silver nanoparticles
(AgNPs)) and cells treated with AgNPs (30 μg/ml).The changes of mitochondrial membrane potential by AgNPs were obtained using fluorescence
microscopy. JC-1 formed red-fluorescent J-aggregates in healthy A549 cells with high MTP, whereas A549 cells exposed to AgNPs had low MTP
and, JC-1 existed as a monomer, showing green fluorescence. L132 cells exposed to AgNPs shows healthy and had high MTP.
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We have demonstrated an easy, simple, and environmen-
tally friendly approach to the synthesis of AgNPs using the
leaf extract of A. princeps as a reducing and stabilizing
agent. In this method, highly crystalline, spherical-shaped
AgNPs with an average size of 20 nm were prepared with-
out using any harmful reducing or capping agents. The
phyto-molecules of the A. princeps extract were not only
responsible for the reduction of AgNO3 but also function
as capping agents to the surfaces of the AgNPs. The novel
AgNPs show multifunctional effects against bacteria and
human cancer cells, yet were biocompatible with normal
lung cells. This suggests that AgNPs could contribute to
develop therapeutic molecules for anticancer and anti-
angiogenic. Interestingly, this comprehensive report de-
scribes the effect of AgNPs in bacteria and human cell
types. Our results highlight a common and possible mech-
anism of cell death in bacteria and human cancer cells that
is due to the generation of ROS, eventually leading to cell
death. We believe that biologically prepared AgNPs could
open a new avenue for various biomedical applications,
particularly infections and cancer.
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